Tackling the complexities of healthcare-related topics in the “Big Easy” may seem like an oxymoron, but PYA and the American Institute of Certified Public Accountants (AICPA) are ready for the challenge. Though the perplexing healthcare environment of-late is certainly not synonymous with easy, the AICPA Healthcare Industry Conference, November 14-15, 2013, at the Roosevelt New Orleans, aims to help industry leaders make sense of these taxing topics.
Leading healthcare experts will cover the latest information in accounting, auditing, legislative, regulatory, legal, tax, valuation, and operational issues. PYA thought leaders will present various sessions, offering insights and tools to help C-suite and other key healthcare professionals implement the latest strategies.
At a pre-conference workshop Wednesday, November 13, PYA Principal Jim Lloyd, along with other presenters, will provide an introduction to Healthcare Valuation 101. They will address:
- Healthcare laws and case law updates.
- Valuation terminology and definitions.
- Types of healthcare transactions being valued.
- Healthcare business valuation approaches and methodology.
- Valuation premiums and discounts.
- Valuation of healthcare compensation arrangements.
- Valuation report writing.
- Commercial reasonableness: What is it and how does one assess it?
During the main conference, PYA Principal Carol Carden will address “Current Reform Initiatives and Their Impact on Physician Compensation.” She will discuss healthcare reform initiatives, such as the movement toward bundled payments, accountable care organizations, increasing emphasis on outcomes data and the value-based payment modifier and their impact on physician compensation. The session also will cover the migration of industry survey benchmark data, how to effectively incorporate quality and outcomes incentives into compensation, and the impact of the recent Office of Inspector General opinion regarding clinical co-management agreement structures.=
Greg Gates, PYA Principal, will speak on “Common Tax Problems in Running a Physician Practice.” His presentation will focus on the practical income tax issues of medical practices to include educating physicians in understanding “phantom income,” justification for dividend payments, S Corporation conversions and physician automobile documentation and reporting requirements.
PYA Principal David McMillan and Senior Manager Chris Wilson will cover “Meaningful Use: Beyond Stage I.” They will review major changes in the Stage 2 Final Rule. They also will explore the “new normal” of meaningful use as a standard in new care/reimbursement model development, as providers move from a world of attestation and implementation to now having access to big data; the latest forms of advanced and actionable data analytics; increased transparency; and other downstream effects. They will demonstrate how meaningful use plays a role in compliance and auditing; becomes a new platform for implementing regulatory efforts such as the Physician Quality Reporting System; and establishes a de facto standard in new care/reimbursement-model development, such as clinically integrated networks and ACOs.
Lloyd also will co-present a session on “Valuation Methods and Strategies for More Tax-Effective Physician Practice Acquisition Transactions.” He will emphasize the pros and cons of various deal structures and the potential tax savings available from allocating a portion of the purchase price to the physician’s professional goodwill and/or other intangible assets.
McMillan additionally is speaking about “Community Benefit: One Term, Many Contexts.” He will introduce participants to the concept of community benefit related to healthcare transactions involving the divestiture or alignment of the assets owned by public entities or private not-for-profit corporations, giving particular attention to:
- Historical use of the term in various contexts.
- Definitions of community benefits utilized by state and national regulatory bodies.
- Application of qualitative and quantitative measures utilized when evaluating community benefits in a healthcare transaction.
- Fair market value and commercial reasonableness considerations.
If you’d like to request one of our PYA thought leaders to speak on any of the topics above, contact one of our executives listed below at (800) 270-9629.
